A growing number of people are exploring lower-dose approaches to GLP-1 medications
Wang Y, Sharma RK, Falcone T, Goldberg J, Agarwal A
A Nature genetics paper (April 2026, n=27,885) identified GLP1R and GIPR variants predicting response and side-effect risk
When prepared by a licensed 503B compounding pharmacy and administered at the correct therapeutic doses, clinical outcomes are equivalent
GLP-1 Ozempic weight loss prescriptions with ongoing care A once weekly injectable GLP-1 that is indicated for the treatment of Type 2 Diabetes* Slows down digestion to stay fuller, longer 1 Get started *Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a providers discretion and professional judgement
Activation of the GLP-1 receptor signals the brain to feel full with smaller meals, while the GIP receptor improves sugar processing and insulin regulation